SUBSCRIBE
SUBSCRIBE

Nevada

PRESS RELEASES
Press Releases
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors
February 3, 2025
 · 
3 min read
Press Releases
Corstasis Therapeutics Inc. Announces FDA Acceptance of New Drug Application for Bumetanide Nasal Spray
January 27, 2025
 · 
2 min read
Press Releases
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
January 21, 2025
 · 
2 min read
Press Releases
Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
January 21, 2025
 · 
3 min read
Press Releases
Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week
January 10, 2025
 · 
6 min read
Press Releases
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis
December 23, 2024
 · 
8 min read
Press Releases
Secura Bio Presented New Data from its Phase 2 PRIMO Trial of Copiktra® (Duvelisib) in Relapsed or Refractory Peripheral T-cell Lymphoma and Announced Plans for its Phase 3 TERZO Trial at the 2024 American Society of Hematology Meeting
December 10, 2024
 · 
8 min read
Press Releases
New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) Presented at the 2024 American Society of Hematology Meeting
December 10, 2024
 · 
7 min read
Press Releases
BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™
November 25, 2024
 · 
2 min read
Press Releases
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference
November 25, 2024
 · 
1 min read
Press Releases
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
November 20, 2024
 · 
5 min read
Press Releases
Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes
November 18, 2024
 · 
5 min read
Press Releases
Corstasis Therapeutics to Present Pivotal Trial Data on Novel Bumetanide Nasal Spray at American Heart Association Scientific Sessions 2024
November 15, 2024
 · 
2 min read
Press Releases
Secura Bio Appoints Dr. Patrick Vink as Chairman of the Board of Directors
November 15, 2024
 · 
2 min read
Press Releases
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
November 14, 2024
 · 
7 min read
Press Releases
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
November 7, 2024
 · 
10 min read
Press Releases
Secura Bio Announces Poster Presentation Highlighting New COPIKTRA® (duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2024 American Society of Hematology Meeting
November 6, 2024
 · 
7 min read
Press Releases
Final Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24
November 6, 2024
 · 
15 min read
Press Releases
First Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24
November 5, 2024
 · 
17 min read
Press Releases
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded
November 5, 2024
 · 
4 min read
Load More